Tuesday
SESSION 3: TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT
SESSION 3 SCHEDULE
9:13 AM - 9:18 AM New MR Imaging Techniques (4D) To Measure Vascular Hemodynamics And Biomechanics: How Can They Help In Treating Patients With TBADs
  Presenter(s):Rachel E. Clough, MD, PhD  
  View Abstract      
9:19 AM - 9:24 AM Tips And Tricks For Avoiding Pitfalls In The TEVAR Treatment Of TBADs: Based On Experience In More Than 1800 Patients
  Presenter(s):Wei Guo Fu, MD  
  View Abstract      
FOUR-WAY DEBATE
9:25 AM - 9:30 AM DEBATE: All “Uncomplicated” TBADs Should Be Treated Early By TEVAR Since All Are Or Will Become Complicated: INSTEAD XL And IRAD Prove It And We Don’t Need Further Trials
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Abstract      
9:31 AM - 9:36 AM DEBATE: Why We Still Need A Randomized Controlled Trial (RCT) Of Intensive Medical Therapy vs. Early TEVAR For Uncomplicated TBAD
  Presenter(s):Frank A. Lederle, MD  
  View Abstract      
9:37 AM - 9:42 AM DEBATE: Medical Therapy And Close Observation Is Best For Uncomplicated TBAD: When Complications Arise, Most Patients Are Best Treated With Open Operation: Long-Term Results (>20 Years) Justify It
  Presenter(s):Hazim J. Safi, MD / Ali Azizzadeh, MD  
  View Abstract      
9:43 AM - 9:48 AM DEBATE: With Patients Having Uncomplicated TBAD Medical Treatment With Delayed (2-3 Months) TEVAR Is The Best Treatment: It Will Lessen Complications Including Retrograde Type A Dissections
  Presenter(s):Matt M. Thompson, MD  
  View Abstract      
9:49 AM - 9:54 AM Current Single Center Results Of Medically Treated TBAD Patients
  Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD  
  View Abstract      
9:55 AM - 10:00 AM Why We Need A New Classification System For Patients With TBAD: What Is It
  Presenter(s):Christoph A. Nienaber, MD, PhD / Michael D. Dake, MD  
  View Abstract      
10:01 AM - 10:10 AM Panel Discussion
10:10 AM - 10:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 3
previous next